Diagnosis and therapy of chromoblastomycosis
DOI:
https://doi.org/10.66344/jpad.32.2.2022.1901Abstract
Chromoblastomycosis is a chronic deep mycosis of the skin and subcutaneous tissue. Clinical features are characterized by verrucous plaque lesions, especially in the lower extremities. The disease is difficult to cure and there is no gold standard therapy. A 72-year-old male farmer comes with thickened and bleeding skin on the left leg. For 10 years the thickened skin extends slowly from the back of the foot to the length of the left leg down to the bottom of the knee. A month earlier, the thickened skin becomes brittle and bleeding. hyperkeratotic plaques, verrucosa, multiple partial exudative, and hemorrhagic fissures. Scrapping skin lesions with 10% potassium hydroxide showing muriform cell (sclerotic bodies). Histopathological examination of granuloma inflammation composed of foamy macrophages, lymphocytes, histiocytes, multinucleated giant cells and many neutrophils, erythrocyte extravasation, and sclerotic bodies obtained in the brown dermis. Culture on Sabouraud dextrose agar media with chloramphenicol was not found in fungal colony growth. Patients have been treated with itraconazole 200 mg twice daily and showed clinical improvement after 3 weeks. Diagnosis of chromoblastomycosis is based on history, physical examination, histopathology, and culture. The risk factors for the disease including farmers who work barefoot. Further evaluation is still needed regarding the therapy and complications in this case.Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.